CRP as a Predictor of Benefit from AtorvastatinCRP as a Predictor of Benefit from Atorvastatin
Are baseline and on-statin CRP independent predictors of cardiovascular outcome -- beyond low-density lipoprotein cholesterol? Journal of the American College of Cardiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 6, 2013 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Reilly announces 30 per cent reduction in cost of anti-cholesterol drug
Atorvastatin, also known as Lipitor, will be set at 70 per cent of the current price (Source: The Irish Times - Health)
Source: The Irish Times - Health - September 2, 2013 Category: Consumer Health News Source Type: news
Diabetes Sufferers Offered Legal Help By Lancaster Firm
Lipitor, one of the most common and popular drugs in the world, is increasingly being linked to the development of diabetes in women. Numerous reports of adversity have led the Lancaster personal...(PRWeb August 29, 2013)Read the full story at http://www.prweb.com/releases/2013/8/prweb11058583.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 31, 2013 Category: Pharmaceuticals Source Type: news
Lipitor Lawsuit Motion to Consolidate Denied
Levin, Papantonio law firm continues to investigate Lipitor lawsuit claims despite Judge’s decision to deny motion to consolidate.(PRWeb August 19, 2013)Read the full story at http://www.prweb.com/releases/Lipitor-lawsuit/MDL-denied/prweb11036662.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 20, 2013 Category: Pharmaceuticals Source Type: news
Baron and Budd Begins Participation in Lipitor Lawsuit
The National Law Firm Announces Handling of Lipitor Lawsuit Cases Involving the Alleged Development of Type 2 Diabetes in Women Taking the Popular Cholesterol Lowering Drug(PRWeb July 20, 2013)Read the full story at http://www.prweb.com/releases/2013/7/prweb10946708.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 22, 2013 Category: Pharmaceuticals Source Type: news
The Onder Law Firm Offers Lipitor Diabetes Attorney Consultation to...
National pharmaceutical litigation law firm offers confidential case review to Lipitor users who have been diagnosed with diabetes.(PRWeb July 16, 2013)Read the full story at http://www.prweb.com/releases/lawsuit/lipitor-diabetes/prweb10932661.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 18, 2013 Category: Pharmaceuticals Source Type: news
Attorney John J. Driscoll Calls Attention to New Report on Lipitor and...
Lawyer from The Driscoll Firm, P.C., says Lipitor patients may be alarmed and wondering about their legal rights in light of growing medical research associating Lipitor and other statin drugs with a...(PRWeb July 13, 2013)Read the full story at http://www.prweb.com/releases/drug-injury-lawyer/lipitor-and-diabetes-risk/prweb10924527.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 13, 2013 Category: Pharmaceuticals Source Type: news
Well: Ask Well: Women and Statins
Gina Kolata answers a reader’s question about the benefits of taking statins for women. (Source: NYT Health)
Source: NYT Health - July 11, 2013 Category: Consumer Health News Authors: By GINA KOLATA Tags: Ask Well Cholesterol Lipitor (Drug) medicine and health Statins (Cholesterol-Lowering Drugs) Featured Source Type: news
Injury Lawyers Release New Informational Graphic about the Possible...
d’Oliveira & Associates has released a new infographic on Lipitor including information on recent FDA warnings and medical studies.(PRWeb June 29, 2013)Read the full story at http://www.prweb.com/releases/2013/6/prweb10878253.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 30, 2013 Category: Pharmaceuticals Source Type: news
New Report Examines Efforts To Reduce The Impact Of Generic Competition For Popular Drug Lipitor
AARP's Public Policy Institute have released a new Rx Price Watch report examining efforts by Pfizer to reduce the impact of generic competition for the popular anti-cholesterol drug Lipitor. The report breaks down the unusually aggressive strategy reportedly undertaken by Lipitor's manufacturer before and after the drug's patent expired and discusses how the effort could become a model for other brand name drug manufacturers facing generic competition, ultimately increasing costs for consumers and publicly-funded programs like Medicare and Medicaid... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 15, 2013 Category: Consumer Health News Tags: Public Health Source Type: news
Liptruzet: Why Prescribe It?Liptruzet: Why Prescribe It?
Dr. Howard Weintraub discusses the recent approval of Liptruzet, the atorvastatin/ezetimibe combination used to treat elevated LDL-cholesterol levels. Medscape Cardiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 13, 2013 Category: Consumer Health News Tags: Cardiology Expert Interview Source Type: news
Liptruzet (ezetimibe and atorvastatin) for the Treatment of Hyperlipidaemia
Liptruzet (ezetimibe and atorvastatin) is a combination drug indicated to reduce elevated low-density lipoprotein (LDL) cholesterol in patients suffering from hyperlipidaemia disorder. (Source: Drug Development Technology)
Source: Drug Development Technology - June 5, 2013 Category: Pharmaceuticals Source Type: news
NSF International Releases Atorvastatin Calcium Reference Standard Kits to Help Manufacturers in India Maintain the Highest Quality Standards
NSF International, an independent global public health organization that develops high quality reference standards, now has Atorvastatin Calcium Reference Standard Kits, which are traceable to official US (USP) and European pharmacopeial (EP) standar… (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - June 5, 2013 Category: Pharmaceuticals Source Type: news
Statin Drugs May Increase Risk Of Diabetes
Certain statins - also known as cholesterol-lowering medications - could increase your risk of developing type 2 diabetes, a new study suggests. The risk was most significant in patients taking atorvastatin (Lipitor), rosuvastatin (Crestor) and simvastatin (Zocor), according to the study, published in BMJ. Statins are the most widely prescribed medications for the prevention of cardiovascular events. Generally, these medications are well received, however, a new link to diabetes has been suggested. Previous studies have indicated a 27% elevated risk of diabetes with rosuvastatin... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 24, 2013 Category: Consumer Health News Tags: Statins Source Type: news
Risk of Diabetes With Statins Risk of Diabetes With Statins
While one study is reassuring for older patients treated with statins, with researchers finding no evidence of an increased risk of diabetes in acute coronary syndrome patients, the other suggests that the more potent statins, such as rosuvastatin, atorvastatin, and simvastatin, do pose an increased risk compared with pravastatin. Heartwire (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 24, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news
